Conquering Diseases

Study Of An Investigational Drug To Reduce Tumors In Children With Advanced Cancer


Seeking people aged 1-21 years old with certain kinds of solid tumor cancer for a study of an investigational drug.


Participants in this study will take the investigational drug tipifarnib during 28-day cycles for a period of up to 2 years.

What we're hoping for

We are studying an investigational drug called tipifarnib to reduce certain kinds of tumors in children aged 1 to 21 years old whose cancer has returned or gotten worse after treatment.

Additional Information Identifier: NCT04284774

 Principal Investigator

Stefanie  Lowas, MD

UMass Chan Medical School

 Study Contact

Danielle  Pichette-Patsky

+1 508-856-3077


UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655